A distal super-enhancer activates oncogenic ETS2 via recruiting MECOM in inflammatory bowel disease and colorectal cancer
Yongheng Chen(Hunan Cancer Hospital), Xing‐sheng Shu(Chongqing Municipal Government)
Cited by 24
Related Papers
Recent advances in therapeutic strategies for triple-negative breast cancer
|Journal of Hematology & Oncology|2022|892
Targeting p53 pathways: mechanisms, structures and advances in therapy
|Signal Transduction and Targeted Therapy|2023|857
Thallium pollution in China and removal technologies for waters: A review
|Environment International|2019|269
Thallium contamination in farmlands and common vegetables in a pyrite mining city and potential health risks
|Environmental Pollution|2019|172
Structural insight into the molecular mechanism of p53-mediated mitochondrial apoptosis
|Nature Communications|2021|114